Tela Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary

TELA Bio

11/05/2023 22:01

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 63
cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 56 cents per share.
    * Revenue rose 44.7% to $11.91 million from a year ago;
analysts
expected $12.02 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 63
cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * TELA Bio Inc shares had fallen by 6.5% this quarter and
lost 13.5% so far this year.
    * The company reported a quarterly loss of $12.03 million.
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.56          -0.63          Missed
 Dec. 31 2022      -0.55          -0.52          Beat
 Sep. 30 2022      -0.63          -0.64          Missed
 Jun. 30 2022      -0.62          -0.79          Missed